Lenis

Lenis is a specialty pharmaceutical company headquartered in Slovenia that focuses on providing access to niche, orphan, and unlicensed medicines. The company specializes in the sourcing, registration, and distribution of hard-to-find pharmaceuticals for hospitals and pharmacies across the Adriatic region. In December 2021, Lenis was acquired by Medis, a prominent commercialization partner for innovative pharmaceuticals in Central and Eastern Europe. Their business model centers on bridging the gap for patients with rare diseases and critical medical needs through a robust supply chain and regulatory expertise. The company manages a diverse portfolio that includes treatments for oncology, hematology, and emergency medicine.